141 related articles for article (PubMed ID: 28055296)
1. Eradication of melanoma in vitro and in vivo via targeting with a Killer-Red-containing telomerase-dependent adenovirus.
Takehara K; Yano S; Tazawa H; Kishimoto H; Narii N; Mizuguchi H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
Cell Cycle; 2017 Aug; 16(16):1502-1508. PubMed ID: 28055296
[TBL] [Abstract][Full Text] [Related]
2. Eradication of osteosarcoma by fluorescence-guided surgery with tumor labeling by a killer-reporter adenovirus.
Yano S; Miwa S; Kishimoto H; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
J Orthop Res; 2016 May; 34(5):836-44. PubMed ID: 26479501
[TBL] [Abstract][Full Text] [Related]
3. Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery.
Kuroda S; Fujiwara T; Shirakawa Y; Yamasaki Y; Yano S; Uno F; Tazawa H; Hashimoto Y; Watanabe Y; Noma K; Urata Y; Kagawa S; Fujiwara T
Cancer Res; 2010 Nov; 70(22):9339-48. PubMed ID: 21045143
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.
Yano S; Takehara K; Tazawa H; Kishimoto H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
J Cell Biochem; 2017 Nov; 118(11):3635-3642. PubMed ID: 27171483
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral targeting of malignant melanoma for fluorescence-guided surgery prevents recurrence in orthotopic nude-mouse models.
Yano S; Takehara K; Kishimoto H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2016 Apr; 7(14):18558-72. PubMed ID: 26701857
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma.
Yano S; Miwa S; Kishimoto H; Uehara F; Tazawa H; Toneri M; Hiroshima Y; Yamamoto M; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2015 May; 6(15):13133-48. PubMed ID: 26033451
[TBL] [Abstract][Full Text] [Related]
7. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells.
Watanabe Y; Hashimoto Y; Kagawa S; Kawamura H; Nagai K; Tanaka N; Urata Y; Fujiwara T
Cancer Gene Ther; 2012 Nov; 19(11):767-72. PubMed ID: 22956040
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
Fujiwara T; Kagawa S; Kishimoto H; Endo Y; Hioki M; Ikeda Y; Sakai R; Urata Y; Tanaka N; Fujiwara T
Int J Cancer; 2006 Jul; 119(2):432-40. PubMed ID: 16477640
[TBL] [Abstract][Full Text] [Related]
10. Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model.
Yano S; Takehara K; Miwa S; Kishimoto H; Hiroshima Y; Murakami T; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
PLoS One; 2016; 11(2):e0148760. PubMed ID: 26849435
[TBL] [Abstract][Full Text] [Related]
11. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413
[TBL] [Abstract][Full Text] [Related]
12. Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer.
Takehara K; Tazawa H; Okada N; Hashimoto Y; Kikuchi S; Kuroda S; Kishimoto H; Shirakawa Y; Narii N; Mizuguchi H; Urata Y; Kagawa S; Fujiwara T
Mol Cancer Ther; 2016 Jan; 15(1):199-208. PubMed ID: 26625896
[TBL] [Abstract][Full Text] [Related]
13. Telomerase-specific replication-selective virotherapy for human cancer.
Kawashima T; Kagawa S; Kobayashi N; Shirakiya Y; Umeoka T; Teraishi F; Taki M; Kyo S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):285-92. PubMed ID: 14734481
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models.
Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2016 Dec; 7(51):85273-85282. PubMed ID: 27863373
[TBL] [Abstract][Full Text] [Related]
15. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
[TBL] [Abstract][Full Text] [Related]
17. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation.
Kishimoto H; Zhao M; Hayashi K; Urata Y; Tanaka N; Fujiwara T; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14514-7. PubMed ID: 19706537
[TBL] [Abstract][Full Text] [Related]
18. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO
Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
20. OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.
Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Cancer Gene Ther; 2017 Feb; 24(2):45-47. PubMed ID: 28106046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
